Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.
Eliashiv D, Rao VR, Jobst BC, Szaflarski JP, Rolston JD, Kaye LC, Ganguly TM, Bullinger K, Dugan PC, Burdette DE, Peters AY, Sheikh A, Haas KF, Nair DR, Mnatsakanyan L, Quraishi IH, Bensalem-Owen MK; RNS System PAS Study; Doherty MJ, Razavi B, Fisher TL, Skidmore C, Modur PN, Constantino TM, Salanova V, Cole AJ, Taraschenko O, Rivera-Cruz A, Wheless JW, Tandon N, Balabanov A, Aboumatar S, Fried I, Drees C, Shin HW, Jaisani Z, MacIver SE, Patra SE, Chang EF, Willie JT, Gwinn R, Stoub T, Stern JM, Crabtree T, Seale CG, McFadden SC, Norman JF, Johnson L, Morrell MJ.
Eliashiv D, et al.
Neurology. 2026 May 12;106(9):e214875. doi: 10.1212/WNL.0000000000214875. Epub 2026 Apr 24.
Neurology. 2026.
PMID: 42030518
Free PMC article.